Tecnologia educacional para a participação do paciente na administração segura de quimioterápicos antineoplásicos: estudo metodológico 2024
Data
2024-02-27
Autores
Muniz, Elaine Cristina Salzedas 
Orientadores
Bohomol, Elena
Tipo
Tese de doutorado
Título da Revista
ISSN da Revista
Título de Volume
Resumo
Objetivo: elaborar, validar e aplicar uma tecnologia educacional para promover a participação do paciente na administração segura de quimioterápicos antineoplásicos. Método: estudo metodológico desenvolvido em seis etapas: revisão integrativa da literatura; entrevistas semiestruturadas com pacientes com câncer; entrevistas estruturadas com profissionais que atuam em ambulatório de quimioterapia; construção da tecnologia educacional; validação de face e conteúdo pelos juízes; e aplicação da tecnologia educacional com validação semântica pelo público-alvo. Resultados: Foram construídas duas tecnologias educacionais, sendo um infográfico “Nada sobre mim sem mim” e nove cartões de verificação para serem utilizados na estratégia do Método Teach-Back. Na validação de 15 juízes o Índice de Validade de Conteúdo global para o infográfico foi de 82% e o Content Validity Ratio global foi de 0,63 e o Índice de Validade de Conteúdo global para os cartões de verificação foi 84% e o Content Validity Ratioglobal foi 0,75, demonstrando um bom nível de concordância entre os juízes para a tecnologia educacional construída. Na última etapa, a validação semântica foi realizada com a aplicação das tecnologias em 15 pacientes em tratamento quimioterápico por via endovenosa e obteve-se um Índice de Validade Semântica de 0,97. Os sete profissionais consideraram que o instrumento aplicado pode favorecer a participação do paciente para a segurança durante a administração dos quimioterápicos antineoplásicos e pode ser utilizado na prática diária, adequando-o à rotina do serviço. Conclusão: O infográfico “Nada sobre mim sem mim” e os cartões de verificação foram considerados tecnologias educacionais válidas quanto à face, conteúdo e semântica e podem ser utilizados para a participação do paciente durante a administração de quimioterápicos antineoplásicos através da estratégia do Método Teach-Back.
Objective: to develop, validate and apply an educational technology to promote patient participation in the safe administration of antineoplastic chemotherapy drugs. Method: methodological study developed in six stages: integrative literature review; semi-structured interviews with cancer patients; structured interviews with professionals who work in chemotherapy outpatient clinics; construction of educational technology; ; face and content validation by judges; and application of educational technology with semantic validation by the target audience. Results: Two educational technologies were created, one being an infographic “Nothing about me without me” and nine verification cards to be used in the Teach-Back Method strategy. In the validation of 15 judges, the global Content Validity Index for the infographic was 82% and the global Content Validity Ratio was 0.63 and the global Content Validity Index for the verification cards was 84% and the Content Validity Ratioglobal was 0.75, demonstrating a good level of agreement between judges for the educational technology built. In the last stage, semantic validation was carried out by applying the technologies to 15 patients undergoing intravenous chemotherapy treatment and a Semantic Validity Index of 0.97 was obtained. The seven professionals considered that the instrument applied can favor patient participation for safety during the administration of antineoplastic chemotherapy drugs and can be used in daily practice, adapting it to the service routine. Conclusion: The infographic “Nothing about me without me” and the monitoring cards were considered valid educational technologies in terms of face, content and semantics and can be used for patient participation during the administration of antineoplastic chemotherapy drugs through the Teach- Back Method strategy.
Objective: to develop, validate and apply an educational technology to promote patient participation in the safe administration of antineoplastic chemotherapy drugs. Method: methodological study developed in six stages: integrative literature review; semi-structured interviews with cancer patients; structured interviews with professionals who work in chemotherapy outpatient clinics; construction of educational technology; ; face and content validation by judges; and application of educational technology with semantic validation by the target audience. Results: Two educational technologies were created, one being an infographic “Nothing about me without me” and nine verification cards to be used in the Teach-Back Method strategy. In the validation of 15 judges, the global Content Validity Index for the infographic was 82% and the global Content Validity Ratio was 0.63 and the global Content Validity Index for the verification cards was 84% and the Content Validity Ratioglobal was 0.75, demonstrating a good level of agreement between judges for the educational technology built. In the last stage, semantic validation was carried out by applying the technologies to 15 patients undergoing intravenous chemotherapy treatment and a Semantic Validity Index of 0.97 was obtained. The seven professionals considered that the instrument applied can favor patient participation for safety during the administration of antineoplastic chemotherapy drugs and can be used in daily practice, adapting it to the service routine. Conclusion: The infographic “Nothing about me without me” and the monitoring cards were considered valid educational technologies in terms of face, content and semantics and can be used for patient participation during the administration of antineoplastic chemotherapy drugs through the Teach- Back Method strategy.
Descrição
Citação
MUNIZ, Elena Cristina Salzedas. Tecnologia educacional para participação do paciente na administração segura de quimioterápicos antineoplásicos: estudo metodológico. 2024 171 f. Tese (Doutorado) – Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo. 2024.